Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes

被引:18
|
作者
Tripathy, Priyadarshini [1 ]
Sahu, Asutosh [2 ]
Sahu, Mahija [1 ]
Nagy, Attila [3 ]
机构
[1] SCB Med Coll, Dept Obstet & Gynecol, Cuttack 753007, Odisha, India
[2] SCB Med Coll, Dept Radiodiag, Cuttack, Odisha, India
[3] Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary
关键词
Hyperandrogenism; Metabolic syndrome; Obesity; PCOS; Rotterdam phenotypes; ENDOCRINE CHARACTERISTICS; INSULIN-RESISTANCE; PREVALENCE;
D O I
10.1016/j.ejogrb.2018.02.031
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Though polycystic ovarian syndrome (PCOS) is associated with multiple metabolic abnormalities, the metabolic risk profile of various PCOS phenotypes is still debated. Here we sought to compare the clinical, biochemical and metabolic parameters among the different PCOS phenotypes and controls. Study design: A total of 394 newly diagnosed PCOS women and 108 controls were enrolled consecutively. PCOS women were divided into four phenotypes based on the presence of two of the following Rotterdam criteria: oligo/anovulation (O), hyperandrogemsm (H), and polycystic ovaries (P): A (O + H + P), B (O + H), C (H + P), D (O + P). Results: Phenotype A (55.8%) was the most common phenotype in the PCOS cohort. Prevalence of metabolic syndrome was highest in phenotype A and B compared to other two phenotypes and controls. The clinical, biochemical and metabolic characteristics, of phenotypes A and B, were similar, but phenotype A had higher hirsutism score and androgen level. Phenotype C had intermediate metabolic characteristics between A and controls whereas phenotype D had the mildest metabolic abnormalities among the four phenotypes. Significant predictors for metabolic syndrome within the PCOS cohort are waist circumference >80 cm, hypertension, fasting glucose >100 mg/dL, HDL-cholesterol <50 mg/dL and triglyceride >150 mg/dL (p < 0.001). Conclusions: Indian PCOS women with Phenotype A and B he at increased metabolic risk compared to other phenotypes. Phenotypic classification of PCOS women may facilitate more effective application of screening and treatment strategies for high-risk metabolic phenotypes. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 50 条
  • [41] Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome
    Pau, Cindy Ta
    Keefe, Candace C.
    Welt, Corrine K.
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (06) : 551 - 555
  • [42] Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
    Ganie, Mohd Ashraf
    Chowdhury, Subhankar
    Malhotra, Neena
    Sahay, Rakesh
    Bhattacharya, Prasanta Kumar
    Agrawal, Sarita
    Jabbar, P. K.
    Suri, Vanita
    Rozati, Roya
    Sreenivas, Vishnubhatla
    Baba, Mohammad Salem
    Wani, Imtiyaz Ahmad
    Rashid, Haroon
    Nair, Abhilash
    Shukla, Amlin
    Arora, Taruna
    Kulkarni, Bharati
    JAMA NETWORK OPEN, 2024, 7 (10) : e2440583
  • [43] The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome
    Bicer, Nihan Cakir
    Ermis, Asime Aleyna
    Bas, Dilsat
    LIFE-BASEL, 2023, 13 (10):
  • [44] Levels of a novel metabolic marker, spexin in patients with hirsutism: metabolic syndrome risk in idiopathic and polycystic ovarian syndrome (PCOS) hirsutism
    Atakul, Nil
    Kilic, Berna Sermin
    Selek, Sahabettin
    Atamer, Yildiz
    GINEKOLOGIA POLSKA, 2024, 95 (10) : 785 - 790
  • [45] Age Associated Differences in Prevalence of Individual Rotterdam Criteria and Metabolic Risk Factors During Reproductive Age in 446 Caucasian Women with Polycystic Ovary Syndrome
    Glintborg, D.
    Mumm, H.
    Ravn, P.
    Andersen, M.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (09) : 694 - 698
  • [46] Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome
    Krentowska, Anna
    Lebkowska, Agnieszka
    Jacewicz-Swiecka, Malgorzata
    Hryniewicka, Justyna
    Lesniewska, Monika
    Adamska, Agnieszka
    Kowalska, Irina
    ENDOCRINE, 2021, 72 (02) : 400 - 410
  • [47] The association between anthropometric parameters and cardiovascular risk indicators in women with polycystic ovarian syndrome
    Mirdamadi, Ahmad
    Riahinejad, Soheila
    Varnaseri, Samane
    ARYA ATHEROSCLEROSIS, 2020, 16 (01) : 39 - 43
  • [48] Mitochondrial DNA oxidation and content in different metabolic phenotypes of women with polycystic ovary syndrome
    Rojo, Mailen
    Perez, Hernan
    Millan, Andrea Liliana
    Pautasso, Maria Constanza
    Duarte, Alejandra
    Abruzzese, Giselle Adriana
    Motta, Alicia Beatriz
    Frechtel, Gustavo Daniel
    Cerrone, Gloria Edith
    FRONTIERS IN ENDOCRINOLOGY, 2025, 15
  • [49] Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome
    Kumar, Amar Nagesh
    Naidu, Jupalle Nagaiah
    Satyanarayana, Uppala
    Ramalingam, Krishnan
    Anitha, Medabalmi
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2016, 10 (01) : 22 - 28
  • [50] Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome
    Sam, S
    Legro, RS
    Essah, PA
    Apridonidze, T
    Dunaif, A
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (18) : 7030 - 7035